Zevin Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Zevin Asset Management's LLY Position: Q1 2026 in Review
Zevin Asset Management increased its Eli Lilly (LLY) stake by 4.9% in Q1 2026, buying an estimated $653K and bringing the position to 13,737 shares worth $12.6M. The position accounts for 1.75% of the portfolio, ranked #25.
Zevin Asset Management first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $14.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Zevin Asset Management held 13,737 shares of Eli Lilly worth $12.6M as of Q1 2026.
- Zevin Asset Management bought 644 Eli Lilly shares in Q1 2026, an estimated $653K.
- Eli Lilly made up 1.75% of Zevin Asset Management's portfolio in Q1 2026, its #25 holding.
- Zevin Asset Management first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
- Zevin Asset Management's Eli Lilly position peaked at $14.1M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Zevin Asset Management's 13F filing for Q1 2026, filed 7 May 2026.